T cell receptors recognize small changes in peptide ligands leading to different T cell responses. Here, we analyzed a panel of HLA-A2–Tax11-19 reactive T cell clones to examine how small allelic variations of MHC molecules could alter the functional outcome of antigen recognition. Similar to the effects induced by antigenic altered peptide ligands, weak or partial agonistic T cell functions were identified in individual T cell clones with the recognition of MHC-altered peptide ligands (MAPLs). Interestingly, one subtype of HLA-A2 molecules induced an unusual type of partial agonistic function; proliferation without cytotoxicity. Modeling of crystallographic data indicated that polymorphic amino acids in the HLA-A2 peptide binding groove, especially the D-pocket, were responsible for this partial agonism. Reciprocal mutations of the Tax peptide side chain engaging the D-pocket indeed restored the agonist functions of the MHC–peptide complex. Whereas early intracellular signaling events were not efficiently induced by these MAPLs, phosphorylated c-Jun slowly accumulated with sustained long-term expression. These data indicate that MAPLs can induce atypical partial agonistic T cell function through structural and biochemical mechanisms similar to altered peptide ligands.
Skip Nav Destination
Article navigation
7 July 2003
Article|
July 07 2003
Allelic Variation of MHC Structure Alters Peptide Ligands to Induce Atypical Partial Agonistic CD8+ T Cell Function
Dong-Gyun Lim,
Dong-Gyun Lim
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Jacqueline M. Slavik,
Jacqueline M. Slavik
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Katarzyna Bourcier,
Katarzyna Bourcier
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Kathrine J. Smith,
Kathrine J. Smith
2Department of Molecular and Cellular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138
Search for other works by this author on:
David A. Hafler
David A. Hafler
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Dong-Gyun Lim
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Jacqueline M. Slavik
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Katarzyna Bourcier
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Kathrine J. Smith
2Department of Molecular and Cellular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138
David A. Hafler
1Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115
Address correspondence to David A. Hafler, Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Institutes of Medicine, Rm. 786, 77 Ave. Louis Pasteur, Boston, MA 02115-5817. Phone: 617-525-5330; Fax: 617-525-5333; E-mail: [email protected]
The present address of Kathrine J. Smith is GlaxoSmithKline, Third Ave., Harlow, Essex CM19 5AW, UK.
*
Abbreviations used in this paper: APL, altered peptide ligand; CFSE, carboxyl fluorescein succinimidyl ester; LAT, linker for activation of T cells; LCL, lymphoblastoid cell line; MAPK, mitogen-activated protein kinases; MAPL, MHC-altered peptide ligand.
Received:
October 11 2002
Revision Received:
May 01 2003
Accepted:
May 01 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (1): 99–109.
Article history
Received:
October 11 2002
Revision Received:
May 01 2003
Accepted:
May 01 2003
Citation
Dong-Gyun Lim, Jacqueline M. Slavik, Katarzyna Bourcier, Kathrine J. Smith, David A. Hafler; Allelic Variation of MHC Structure Alters Peptide Ligands to Induce Atypical Partial Agonistic CD8+ T Cell Function . J Exp Med 7 July 2003; 198 (1): 99–109. doi: https://doi.org/10.1084/jem.20021796
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement